Floatz logo

Chlorophyllin Copper Complex Sodium

Glioma

Tata Memorial CentremixturePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

94 Active assets in the Glioma cohort.

Asset / SponsorPhaseRating
Olutasidenib
Rigel Pharmaceuticals
Phase 4BBB
Valproic Acid
Medical University of South Carolina
Phase 2B
Irinotecan
Kailin Yang, MD, PhD
Phase 3B
Dianhydrogalactitol
Kintara Therapeutics, Inc.
Phase 2B
Cyclophosphamide
Essen Biotech
Phase 2B

View all 50 →

Same molecule, other indications

Chlorophyllin Copper Complex Sodium is also rated in:

radiation-induced disorderActive
CCC
Indicative · Phase 2
53 / 100
View asset →
rectal neoplasmActive
CCC
Indicative · Phase 2
53 / 100
View asset →
malignant gliomaActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →